• Molecular NameDiphenylpyraline
  • SynonymDiphenylpyralamine; Diphenylpyraline Hydrochloride; Diphenylpyrilene
  • Weight281.399
  • Drugbank_IDDB01146
  • ACS_NO147-20-6
  • Show 3D model
  • LogP (experiment)N/A
  • LogP (predicted, AB/LogP v2.0)4.83
  • pkaN/A
  • LogD (pH=7, predicted)3.22
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-1.98
  • LogSw (predicted, AB/LogsW2.0)0.07
  • Sw (mg/ml) (predicted, ACD/Labs)0.12
  • No.of HBond Donors0
  • No.of HBond Acceptors2
  • No.of Rotatable Bonds4
  • TPSA12.47
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyAn antihistamine.
  • Absorption_valueN/A
  • Absorption (description)Well absorbed after oral administration.
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein binding99.0
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmPossible metabolites include the N-oxide and N-desmethyldiphenylpyraline.
  • Half lifeDerived from urinary excretion data, 24 to 40 h.
  • ExcretionLess than 10% of a dose is excreted in the urine as unchanged drug.
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A